Bridgeway Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $637K | Sell |
|
|||||
|
2025
Q2 | $655K | Sell |
|
|||||
|
2025
Q1 | $854K | Sell |
|
|||||
|
2024
Q4 | $1.06M | Sell |
|
|||||
|
2024
Q3 | $1.04M | Hold |
|
|||||
|
2024
Q2 | $531K | Buy |
|
|||||
|
2024
Q1 | $881K | Sell |
|
|||||
|
2023
Q4 | $972K | Buy |
|
|||||
|
2023
Q3 | $642K | Buy |
|
|||||
|
2023
Q2 | $484K | Buy |
|
|||||
|
2023
Q1 | $343K | Sell |
|
|||||
|
2022
Q4 | $488K | Hold |
|
|||||
|
2022
Q3 | $384K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $401K | Hold |
|
|||||
|
2017
Q2 | $431K | Hold |
|
|||||
|
2017
Q1 | $522K | Hold |
|
|||||
|
2016
Q4 | $376K | Sell |
|
|||||
|
2016
Q3 | $726K | Buy |
|
|||||
|
2016
Q2 | $424K | Hold |
|
|||||
|
2016
Q1 | $395K | Sell |
|
|||||
|
2015
Q4 | $592K | Sell |
|
|||||
|
2015
Q3 | $573K | Buy |
|
|||||
|
2015
Q2 | $627K | Sell |
|
|||||
|
2015
Q1 | $705K | Hold |
|
|||||
|
2014
Q4 | $449K | Sell |
|
|||||
|
2014
Q3 | $567K | Buy |
|
|||||
|
2014
Q2 | $1M | Buy |
|
|||||
|
2014
Q1 | $556K | Buy |
|